The Wayback Machine - https://web.archive.org/web/20160304235821/http://www.medscape.com:80/viewarticle/745228_2

Preoxygenation, Reoxygenation, and Delayed Sequence Intubation in the Emergency Department

Scott D. Weingart, MD

|Disclosures

J Emerg Med. 2011;40(6):661-7. 

 

Discussion

The Pathophysiology of Hypoxemia

To understand oxygenation, it is essential to understand the causes of hypoxemia. These causes are inadequate alveolar oxygenation (low environmental oxygen pressure or alveolar hypoventilation), diffusion abnormalities, dead space (high ventilation, low perfusion [V/Q] mismatch), low V/Q mismatch, shunt, and low venous blood saturation. In the Emergency Department (ED) patient placed on ≥ 0.4 fraction-inspired oxygen (fiO2), all of these problems have inconsequential effects on oxygenation except shunt and low venous blood saturation. See Figure 1 for an explanation of these two phenomena.

Figure 1.

Ventilation/perfusion units. In the normal lung, oxygen enters the alveoli and raises the saturation from the venous level of 70% to 100% by the time it reaches the arterial side. In shunt, no oxygen can get in to the alveoli, so the venous saturation is never increased. In low SvO2 situations, the alveoli are not able to raise the low venous saturation to the normal arterial level. When these two problems are both present, the arterial desaturation becomes even worse.

An anatomical shunt is a direct connection between the arterial and venous blood flow, for example, a septal defect in the heart. When we speak about shunt as the cause of hypoxemia, we are rarely referring to anatomical shunts. Physiologic shunt is the major cause of poor oxygenation in ill ED patients already on supplemental oxygen. A physiologic shunt is caused by areas of alveoli that are blocked from conducting oxygen, but still have intact blood vessels surrounding them. This perfusion without any ventilation leads to a direct mixing of deoxygenated venous blood into the arterial blood. Causes of shunt include pneumonia, atelectasis, pulmonary edema, mucus plugging, and adult respiratory distress syndrome. No matter how high the fiO2, these areas will never have an improved oxygenation because inhaled gas never reaches the blood. The only way to improve oxygenation in these areas of the lungs is to fix the shunt.

Low venous oxygen saturation is also an important cause of hypoxemia in the ED. Venous blood is never fully desaturated when it reaches the lungs. In normal patients, the hemoglobin reaching the lungs has a saturation of ~ 65–70%, therefore, only a small amount of exposure to oxygen can rapidly bring the saturation to 100%. In shock states, the venous blood will arrive at the lungs with lower saturations due to greater tissue extraction. This venous blood will require more exposure to oxygen to reach a saturation of 100%; in injured lungs this may not occur. This problem becomes much more deleterious when combined with physiologic shunt. In this combination, the already abnormally low saturation venous blood mixes directly into the arterial supply.

This should impel the practitioner to always consider the circulatory system when evaluating the patient's respiratory status. If the patient about to be intubated is in shock, attempts to improve and prevent the reduction of cardiac output become methods to improve oxygenation. Tailoring sedative medications to the patient's cardiac status and blood volume is critical.[1,2] If time allows, these patients will also benefit from aggressive preintubation normalization of preload, afterload, and inotropy.[3,4]

Standard ED Preoxygenation

The standard recommended technique for ED preoxygenation is tidal volume breathing of oxygen from a high fiO2 source for at least 3 min or eight vital capacity breaths.[5] When possible, a maximal exhalation preceding the tidal volume breathing improves preoxygenation.[6,7] The non-rebreather mask (NRB), though the routine oxygen source, provides only 65–80% of fiO2.[8] In a healthy non-obese adult patient, these standard techniques have been shown to provide a buffer as long as 8 min before the saturation drops below the critical 90% threshold.[9] In the ill patient with injured lungs, abnormal body habitus, or upregulated metabolism, this time is significantly shortened.[9] In some cases it is impossible to obtain a saturation > 90% before the intubation attempt, regardless of the duration of standard preoxygenation.

A patient with a saturation < 95% on a nasal cannula set to 6 L/min of oxygen is exhibiting at least some degree of shunting, as this setting will provide ~ 0.4 fiO2.[8] If the saturation is < 95% on a NRB, the patient is exhibiting signs of moderate to severe shunting. These latter patients are at risk for a precipitous and dramatic decline in oxygen saturation during the intubation procedure.

We have seen many situations in which a patient preintubation is saturating < 90% even with a NRB; the providers become frustrated, abandon further attempts at preoxygenation, and proceed to the immediate intubation of the patient to improve the saturation. However, if the patient is saturating < 90% before rapid sequence intubation (RSI), they may have an immediate and profound desaturation almost immediately after the RSI drugs are administered. Figure 2 shows the oxygen-hemoglobin dissociation (saturation) curve. The patient in this circumstance is already on the steep portion of this curve and will shortly be at critically low pressures of oxygen.

Figure 2.

Oxyhemoglobin dissociation curve. The shape of the curve demonstrates that at 90% saturation, the patient is at risk of critically low oxygen levels (< 40 mm Hg PaO2) if even a brief period of time elapses without reoxygenation. Patients will take a much longer time to desaturate from 100% to 90% than to go from 90% to 70%.

This abandonment of preoxygenation and rush to premature intubation may be predicated on the fallacy that saturation declines in a linear fashion over time. The shape of the curve in Figure 2 demonstrates that the time to go from 100% to 90% is dramatically longer than the time it takes to go from 90% to injuriously low levels of oxygen pressure resulting in dysrhythmia, seizure, and cardiac arrest.

In this circumstance of low saturation before RSI, many airway experts recommend preoxygenation with a bag/valve/mask device (BVM). When the BVM is manufactured with an appropriate exhalation port and a tight mask seal is obtained, it can deliver > 0.9 fiO2 both when the patient spontaneously breathes and with assisted ventilations.[10] However, this increase from a fiO2 of ~ 0.7 (NRB) to ~ 0.9 (BVM) will do nothing to ameliorate shunt and little to correct low V/Q mismatched alveoli. In addition, it requires a practitioner to maintain an ideal mask seal during the stressful moments of preparing for RSI. If the mask seal is inadequate, room air will be entrained.

Preoxygenation in High-risk Patients

Non-invasive ventilation (NIV) has become a mainstay in the management of respiratory emergencies in most EDs. NIV is also the optimal technique for preoxygenation of high-risk patients. With a properly fitted, full-face NIV mask, fiO2 of ~ 1.0 is assured, and because these masks strap around the patient's head, no practitioner is needed to maintain the mask seal. With a setting of continuous positive airway pressure (CPAP) at 0 cm H2O, this NIV set-up will simply provide a source of nearly 100% oxygen. With increased CPAP settings, shunt can actually be treated and the patient's oxygenation significantly improved.[11-15]

Starting with a CPAP setting of 5 and titrating up to a maximum of 15 cm H2O, 100% saturation can be achieved in patients in whom NRB or BVM preoxygenation did not result in adequate saturations. This strategy requires the NIV machine or, preferably, a standard ventilator standing by in the ED. Unless the ED is consistently staffed with an in-department respiratory therapist, it is also necessary for the clinicians to know how to immediately set up and apply NIV themselves.

In EDs where neither a ventilator nor a NIV machine is available, the patient can be preoxygenated by spontaneously breathing through a BVM with a positive end-expiratory pressure (PEEP) valve attached. This is suboptimal, as a provider must hold the mask tightly over the patient's face and even a slight break in the mask seal eliminates the PEEP. PEEP valves will be discussed in more detail below.

Oxygenation During the Apneic Period

In standard RSI, the oxygen mask is left on the patient's face until the time of intubation. However, nothing is done to maintain a patent connection between the mouth and the glottis. As the sedative and paralytic drugs take effect, the tongue and the posterior pharyngeal tissues can occlude the passageway of oxygen to the glottis. Although this seems irrelevant as the patient is no longer breathing, it ignores the benefits of apneic oxygenation.

Apneic Oxygenation

In an experiment by Frumin et al., patients were preoxygenated, intubated, paralyzed, and placed on an anesthesia machine that provided 1.0 fiO2 and no ventilations.[16] These patients were maintained in this apneic state for between 18 and 55 min. None of these patients desaturated below 98%, despite being paralyzed and receiving no breaths. Although their CO2 levels rose, their oxygenation was maintained due to apneic oxygenation. Oxygen was absorbed from the patients' alveoli by pulmonary blood flow; this established a gradient for the continued pull of oxygen from the endotracheal tube and anesthesia circuit. In another study, Teller et al. showed that pharyngeal insufflation with oxygen significantly extended the time to desaturation during apnea.[17] Numerous studies on apneic oxygenation during brain death testing confirm that even without any respiratory effort, oxygen saturation can be maintained.[18-20]

If a continuous path of oxygen is maintained from the pharynx to the glottis during the apneic period of RSI, the patient will continue to oxygenate. This has led us to perform a jaw thrust in all high-risk patients during their apneic period. In some cases, we also place nasopharyngeal airways to augment the passage of oxygen. These techniques, combined with high-flow O2 from a NRB mask, NIV mask, or the facemask of a BVM, will allow continued apneic oxygenation.

Another problem during the apneic period is absorption atelectasis due to alveoli filled with near 100% oxygen. The nitrogen in normally ventilated alveoli serves to maintain their patency. When we preoxygenate with high fiO2, our goal is to completely wash out this nitrogen. This can lead to alveolar collapse as the oxygen is taken up by pulmonary blood; further shunt is the result.[21] The use of NIV ventilation with CPAP can maintain these alveoli in an open state during the apneic period. When NIV is combined with a jaw thrust and patent oro/nasopharyngeal passage of air, the potential benefits of apneic oxygenation can be fully realized.

 
Latest in Emergency Medicine

References

  1. Takizawa D, Takizawa E, Miyoshi S, Kawahara F, Hiraoka H. The increase in total and unbound propofol concentrations during accidental hemorrhagic shock in patients undergoing liver transplantation. Anesth Analg 2006;103:1339–40.

  2. Johnson KB, Egan TD, Kern SE, McJames SW, Cluff ML, Pace NL. Influence of hemorrhagic shock followed by crystalloid resuscitation on propofol: a pharmacokinetic and pharmacodynamic analysis. Anesthesiology 2004;101:647–59.

  3. Ezri T, Szmuk P, Warters RD, Gebhard RE, Pivalizza EG, Katz J. Changes in onset time of rocuronium in patients pretreated with ephedrine and esmolol—the role of cardiac output. Acta Anaesthesiol Scand 2003;47:1067–72.

  4. Szmuk P, Ezri T, Chelly JE, Katz J. The onset time of rocuronium is slowed by esmolol and accelerated by ephedrine. Anesth Analg 2000;90:1217–9.

  5. Pandit JJ, Duncan T, Robbins PA. Total oxygen uptake with two maximal breathing techniques and the tidal volume breathing technique: a physiologic study of preoxygenation. Anesthesiology 2003;99:841– 6.

  6. Baraka AS, Taha SK, El-Khatib MF, Massouh FM, Jabbour DG, Alameddine MM. Oxygenation using tidal volume breathing after maximal exhalation. Anesth Analg 2003;97:1533–5.

  7. Nimmagadda U, Salem MR, Joseph NJ, Miko I. Efficacy of preoxygenation using tidal volume and deep breathing techniques with and without prior maximal exhalation. Can J Anaesth 2007;54:448 –52.

  8. Benumof J, Hagberg CA. Benumof's airway management: principles and practice, 2nd edn. Philadelphia, PA: Mosby; 2007.

  9. Benumof JL, Dagg R, Benumof R. Critical hemoglobin desaturation will occur before return to an unparalyzed state following 1 mg/kg intravenous succinylcholine. Anesthesiology 1997;87:979–82.

  10. Nimmagadda U, Salem MR, Joseph NJ, et al. Efficacy of preoxygenation with tidal volume breathing. Comparison of breathing systems. Anesthesiology 2000;93:693– 8.

  11. Antonelli M, Conti G, Rocco M, et al. Noninvasive positive-pressure ventilation vs. conventional oxygen supplementation in hypoxemic patients undergoing diagnostic bronchoscopy. Chest 2002;121:1149 –54.

  12. Baillard C, Fosse JP, Sebbane M, et al. Noninvasive ventilation improves preoxygenation before intubation of hypoxic patients. Am J Respir Crit Care Med 2006;174:171–7.

  13. Delay JM, Sebbane M, Jung B, et al. The effectiveness of noninvasive positive pressure ventilation to enhance preoxygenation in morbidly obese patients: a randomized controlled study. Anesth Analg 2008;107:1707–13.

  14. El-Khatib MF, Kanazi G, Baraka AS. Noninvasive bilevel positive airway pressure for preoxygenation of the critically ill morbidly obese patient. Can J Anaesth 2007;54:744 –7.

  15. Lopera JL, Quintana S. Noninvasive ventilation versus nonrebreather bag-valve mask to achieve preoxygenation before intubation of hypoxic patients. Am J Respir Crit Care Med 2006;174:1274; author reply 1274.

  16. Frumin MJ, Epstein RM, Cohen G. Apneic oxygenation in man. Anesthesiology 1959;20:789 –98.

  17. Teller LE, Alexander CM, Frumin MJ, Gross JB. Pharyngeal insufflation of oxygen prevents arterial desaturation during apnea. Anesthesiology 1988;69:980 –2.

  18. Marks SJ, Zisfein J. Apneic oxygenation in apnea tests for brain death. A controlled trial. Arch Neurol 1990;47:1066–8.

  19. Wijdicks EF, Rabinstein AA, Manno EM, Atkinson JD. Pronouncing brain death: contemporary practice and safety of the apnea test. Neurology 2008;71:1240–4.

  20. Levesque S, Lessard MR, Nicole PC, et al. Efficacy of a T-piece system and a continuous positive airway pressure system for apnea testing in the diagnosis of brain death. Crit Care Med 2006;34:2213–6.

  21. Reber A, Engberg G, Wegenius G, Hedenstierna G. Lung aeration. The effect of pre-oxygenation and hyperoxygenation during total intravenous anaesthesia. Anaesthesia 1996;51:733–7.

  22. Lawes EG, Campbell I, Mercer D. Inflation pressure, gastric insufflation and rapid sequence induction. Br J Anaesth 1987;59:315–8.

  23. Aufderheide TP, Sigurdsson G, Pirrallo RG, et al. Hyperventilation-induced hypotension during cardiopulmonary resuscitation. Circulation 2004;109:1960 –5.

  24. O'Neill JF, Deakin CD. Do we hyperventilate cardiac arrest patients? Resuscitation 2007;73:82–5.

  25. von Goedecke A, Voelckel WG, Wenzel V, et al. Mechanical versus manual ventilation via a face mask during the induction of anesthesia: a prospective, randomized, crossover study. Anesth Analg 2004;98:260 –3.

  26. von Goedecke A, Wenzel V, Hormann C, et al. Effects of face mask ventilation in apneic patients with a resuscitation ventilator in comparison with a bag-valve-mask. J Emerg Med 2006;30:63–7.

  27. Walls RM, Murphy MF. Manual of emergency airway management, 3rd edn. Philadelphia, PA: Lippincott Williams & Wilkins; 2008.

  28. Aroni F, Iacovidou N, Dontas I, Pourzitaki C, Xanthos T. Pharmacological aspects and potential new clinical applications of ketamine: reevaluation of an old drug. J Clin Pharmacol 2009;49:957–64.

  29. Carollo DS, Nossaman BD, Ramadhyani U. Dexmedetomidine: a review of clinical applications. Curr Opin Anaesthesiol 2008;21:457–61.

  30. Abdelmalak B, Makary L, Hoban J, Doyle DJ. Dexmedetomidine as sole sedative for awake intubation in management of the critical airway. J Clin Anesth 2007;19:370 –3.

  31. Bergese SD, Khabiri B, Roberts WD, Howie MB, McSweeney TD, Gerhardt MA. Dexmedetomidine for conscious sedation in difficult awake fiberoptic intubation cases. J Clin Anesth 2007;19:141– 4.

  32. Grant SA, Breslin DS, MacLeod DB, Gleason D, Martin G. Dexmedetomidine infusion for sedation during fiberoptic intubation: a report of three cases. J Clin Anesth 2004;16:124–6.

  33. Cooper L, Samson R, Gallagher C, Barron M, Candiotti K. Dexmedetomidine provides excellent sedation for elective, awake fiberoptic intubation. Anesthesiology 2005;103:A1449.

Authors and Disclosures

Scott D. Weingart, MD

Division of Emergency Critical Care, Department of Emergency Medicine, Mount Sinai School of Medicine, New York, New York

Corresponding Address
Scott D. Weingart, MD, Division of Emergency Critical Care, Department of Emergency Medicine, Mount Sinai School of Medicine, 7901 Broadway, Elmhurst, NY 11373

Figure 1.

Ventilation/perfusion units. In the normal lung, oxygen enters the alveoli and raises the saturation from the venous level of 70% to 100% by the time it reaches the arterial side. In shunt, no oxygen can get in to the alveoli, so the venous saturation is never increased. In low SvO2 situations, the alveoli are not able to raise the low venous saturation to the normal arterial level. When these two problems are both present, the arterial desaturation becomes even worse.

Figure 2.

Oxyhemoglobin dissociation curve. The shape of the curve demonstrates that at 90% saturation, the patient is at risk of critically low oxygen levels (< 40 mm Hg PaO2) if even a brief period of time elapses without reoxygenation. Patients will take a much longer time to desaturate from 100% to 90% than to go from 90% to 70%.

processing....

All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.